Commonly it is administered as 500 mcg per week for 6 weeks then maintenance dose is continued which is 500mcg per 2-4 weeks, as per vets findings
Zepbound is administered as a once-weekly subcutaneous injection, with dosing initiated at 2.5 mg for 4 weeks, then increased by 2.5 mg every 4 weeks until the target maintenance dose (5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg weekly) is reached, based on individual response and tolerability
Dastan et al
The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (the diabetes and aging study)
Emerging research involving tripeptides as anticancer agents has explored alternative strategies to improve survival rates in cancer patients worldwide
Furthermore, the inability to measure GSH levels in the CNS has markedly impaired the development of new trials focused on increasing GSH levels